Pharmacological characterization of the anti-inflammatory effect of mepolizumab and benralizumab in a human ex vivo model of asthma
P. Rogliani (Roma (RM), Italy), F. Facciolo (Roma (RM), Italy), E. Melis (Roma (RM), Italy), B. Ritondo (Roma (RM), Italy), M. Gabriele (Roma (RM), Italy), A. Perduno (Roma (RM), Italy), J. Ora (Roma, Italy), L. Calzetta (Parma, Italy), J. Ora (Roma (RM), Italy)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4307
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Rogliani (Roma (RM), Italy), F. Facciolo (Roma (RM), Italy), E. Melis (Roma (RM), Italy), B. Ritondo (Roma (RM), Italy), M. Gabriele (Roma (RM), Italy), A. Perduno (Roma (RM), Italy), J. Ora (Roma, Italy), L. Calzetta (Parma, Italy), J. Ora (Roma (RM), Italy). Pharmacological characterization of the anti-inflammatory effect of mepolizumab and benralizumab in a human ex vivo model of asthma. 4307
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|